Peripheral blood lymphocytes from patients with bipolar disorder demonstrate apoptosis and differential regulation of advanced glycation end products and s100b

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 7, 2014, Pages 999-1007

  Moutsatsou, Paraskevi ^b   Tsoporis, James N ^a   Salpeas, Vasileios ^b   Bei, Ekaterini ^b   Alevizos, Basel ^c   Anagnostara, Chrysoula ^c   Izhar, Shehla ^d   Proteau, Gerald ^d   Rizos, Emmanouil ^e   Hatziagelaki, Erifili ^b   Toumpoulis, Ioannis K ^c   Rizos, Ioannis K ^b   Parker, Thomas G ^d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY OF TORONTO   (Canada)

^e NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Advanced glycation end products; Apoptosis; Bipolar disorder; Lymphocytes; S100B

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CASPASE 3; CYTOCHROME C; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN S100B; SUPEROXIDE DISMUTASE; S100B PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; MALE; MENTAL PATIENT; PATHOGENESIS; PATHOPHYSIOLOGY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; AGED; BLOOD; LYMPHOCYTE; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; APOPTOSIS; BIPOLAR DISORDER; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; YOUNG ADULT;

EID: 84903724207     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0978     Document Type: Article

References (57)

1. Hains AB, Arnsten AF. Molecular mechanisms of stress-induced prefrontal cortical impairment: implications for mental illness. Learn Mem 2008;15:551-64.
2. Gigante AD, Young LT, Yatham LN, Andreazza AC, Nery FG, Grinberg LT, et al. Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol 2011;14: 1075-89.
3. Szuster-Ciesielska AM, Słotwinska M, Stachura A, Marmurowska-Michałowska H, Dubas-Slemp H, Bojarska- Junak A, et al. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2008;32: 686-94.
4. Hosokawa T, Momose T, Kasai K. Brain glucose metabolism difference between bipolar and unipolar mood disorders indepressed and euthymic states. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:243-50.
5. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004;61:450-8.
6. Naydenov AV, MacDonald ML, Ongur D, Cotto JJ. Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Arch Gen Psychiatry 2007;64:555-64.
7. Brownlee M. Advanced glycosylation in diabetes and aging. Annu Rev Med 1995;46:223-34.
8. Mahali S, Raviprakash N, Raghavendra PB, Manna SK. Advanced glycation end products (AGEs) induce apoptosis via a novel pathway: involvement of Ca2+ mediated interleukin-8 protein. J Biol Chem 2011;286:34903-13.
9. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, et al. S100B's double life: intracellular regulator and extracellular signal. Intracellular and extracellular roles of S100 proteins. Biochim Biophys Acta 2009;1793:1008-22.
10. Scotto C, Deloulme JC, Rousseau D, Chambaz E, Baudier J. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol Cell Biol 1998;18:4272-81.
11. Wiesmann M, Wandinger KP, Missler U, Eckhoff D, Rothermundt M, Arolt V, et al. Elevated plasma levels of S-100b protein in schizophrenic patients. Biol Psychiatry 1999;45:1508-11.
12. Arolt V, Peters M, Erfurth A, Wiesmann M, Missler U, Rudolf S, et al. S100B and response to treatment in major depression: A pilot study. Eur Neuropsychopharmacol 2003;13:235-9.
13. Steiner J, Walter M, Wunderlich MT. A new pathophysiological aspect of S100B in schizophrenia: potential regulation of S100B by its scavenger soluble RAGE. Biol Psychiatry 2009;13:1107-10.
14. Suchankova P, Klang J, Cavanna C, Holm G, Nilsson S, Jonsson EG, et al. Is the Gly82Ser polymorphism in the RAGE gene relevant to schizophrenia and the personality trait psychoticism? J Psychiatry Neurosci 2012;37:122-8.
15. Daborg J, von Otter M, Sjolander A, Nilsson S, Minthon L, Gustafson DR, et al. Association of the RAGE G82S polymorphism with Alzheimer's disease. J Neural Transm 2010;117:861-7.
16. Ponath G, Schettler C, Kaestener F, Voigt B, Wentker D, Arolt V, et al. S100B effects on astrocytes are mediated via RAGE. J Neuroimmunol 2007;184:214-22.
17. Steiner J, Bernstein HG, Bogerts B, Gos T, Richter-Landsberg C, Wunderlich MT, et al. S100B is expressed in, and released from, OLN-93 oligodendrocytes: influence of serum and glucose deprivation. Neuroscience 2008;154:496-503.
18. Steiner J, Marquardt N, Pauls I, Schiltz I, Rahmoune H, Bahn S, et al. Human CD8(+) T cells and NK cells express and secrete S100B upon stimulation. Brain Behav Immun 2011;25:1233-41.
19. Schroeter ML, Abdul-Khaliq H, Sacher J, Steiner J, Blasig IE, Mueller K. Mood disorders are glial disorders: evidence from in vivo studies. Cardiovasc Psychiatry Neurol 2010;2010:780645.
20. Takahashi K, Yoshino T, Hayashi K, Sonobe H, Ohtsuki Y. S-100 beta positive human T lymphocytes: Their characteristics and behavior under normal and pathologic conditions. Blood 1987;70:214-20.
21. Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, et al. DNA damage in bipolar disorder. Psychiatry Res 2007;153:27-32.
22. Politi P, Brondino N, Emanuele E. Increased proapoptotic serum activity in patients with chronic mood disorders. Arch Med Res 2008;39:242-5.
23. Shao L, Martin MV, Watson SJ, Schatzberg A, Akil H, Myers RM, et al. Mitochondrial involvement in psychiatric disorders. Ann Med 2008;40:281-95.
24. Kim H-W, Rapoport SI, Rao JS. Altered expressions of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis 2010;37:596-603.
25. Bei E, Salpeas V, Pappa D, Anagnostara C, Alevizos V, Moutsatsou P. Phosphorylation status of glucocorticoid receptor, heat shock protein 70, cytochrome c and Bax in lymphocytes of euthymic, depressed and manic bipolar patients, Psychoneuroendocrinol 2009;34:1162-75.
26. Bei ES, Salpeas V, Alevizos B, Anagnostara C, Pappa D, Moustatsou P. Pattern of heat shock factor and heat shock protein expression in lymphocytes of bipolar patients: increased HSP70-glucocorticoid receptor heterocomplex. J Psychiatr Res 2013;47:1725-36.
27. Lowy MT. Reserpine-induced decrease in type I and II corticosteroid receptors in neuronal and lymphoid tissues of adrenalectomized rats. Neuroendocrinol 1990;51:190-6.
28. Spencer RL, Miller AH, Stein M, McEwen BS, Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue. Brain Res 1991;549:236-46.
29. First MB, Spitzer RL, Gibbon M. Structured clinical interview for DSM-IV Axis I disorders, research version. Biometrics Research: New York, 1997.
30. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.
31. Young RC, Briggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-35.
32. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with "miniextracts", prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
33. Tsoporis JN, Izhar S, Leong-Poi H, Desjardins JF, Huttunen HJ, Parker TG. S100B interaction with the receptor for advanced glycation end products (RAGE): A novel receptor-mediated mechanism for myocyte apoptosis postinfarction. Circ Res 2010;106:93-101.
34. Li J, Liu D, Sun L, Lu Y, Zhang Z. Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective. J Neurol Sci 2012;317:1-5.
35. Morimoto RI, Kline MP, Bimston DN. The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem 1997;32:17-29.
36. Poppek D, Grune T. Proteasomal defense of oxidative protein modifications. Antioxid Redox Signal 2006;8:173-84.
37. Schmid K, Haslbeck M, Buchner J, Somoza V. Induction of heat shock proteins and the proteasome system by casein-N epsilon- (carboxymethyl)lysine and N epsilon-(carboxymethyl)lysine in Caco-2 cells. Ann NY Acad Sci 2008;1126:257-61.
38. Verbeke P, Clark BF, Rattan SI. Reduced levels of oxidized and glycoxidized proteins in human fibroblasts exposed to repeated mild heat shock during serial passaging in vitro. Free Radic Biol Med 2001;31:1593-602.
39. Bassi AM, Ledda S, De Pascale MC, Penco S, Rossi S, Odetti P, et al. Antioxidant status in J774A.1 macrophage cell line during chronic exposure to glycated serum. Biochem Cell Biol 2005;83:176-87.
40. Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan E, Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Function 2002;293:2528-30.
41. Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004;19:89-95.
42. Ranjeker PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psych Res 2003;121:109-22.
43. Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LM, Nardin P, et al. Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 2007;41:523-9.
44. Machado-Vieira R, Lara DR, Portela LV, Gonçalves CA, Soares JC, Kapczinski F, et al. Elevated serum S100B protein in drug-free bipolar patients during first manic episode: A pilot study. Eur Neuropsychopharmacol 2002;12:269-72.
45. Ferrari C, Sansoni P, Rowden G. One half of the CD11b+ human peripheral blood T lymphocytes coexpresses the S-100 protein. Clin Exp Immunol 1988;72:357-61.
46. Qi LY, Xiu MH, Chen da C, Wang F, Kosten TA, Kosten TR, et al. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics. Neursci Lett 2009;22:113-7.
47. Steiner J, Schroeter ML, Schiltz K, Bernstein HG, Muller UJ, Richter-Landsberg C, et al. Haloperidol and clozapine decrease S100B release from glial cells. Neuroscience 2010;2:1025-31.
48. Zhang XY, Xiu MH, Song C, Chen da C, Wu GY, Haile CN, et al. Increased serum S100B in never-medicated and medicated schizophrenic paients. J Psych Res 2010;44:1236-40.
49. Nardin P, Tramontina AC, Quincozes-Santos A, Tortorelli LS, Lunardi P, Klein PR, et al. In vitro S100B secretion is reduced by apomorphine: effects of antipsychotics and antioxidants. Prog Neuropsychopharmacol Biol Psychiatry 2011;1:1291-6.
50. Eilat E, Mendlovic S, Doron A. Increased apoptosis in patients with major depression: A preliminary study. J Immunol 1996;163:533-4.
51. Hu J, Van Eldik, LJ. S100B induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochim Biophys Acta 1996;1313:239-45.
52. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation. J Biol Chem 2000;275:40096-105.
53. Tubaro C, Arcuri C, Giambanco I, Donato R. S100B in myoblasts regulates the transition from activation to quiescence to activation, and reduces apoptosis. Biochim Biophys Acta 2011;1813:1092-104.
54. Leclerc E, Fritz G, Weibel M, Heizmann CW, Galichet A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem 2007;43:31317-31.
55. Lin J, Yang Q, Wilder PT, Carrier F, Weber DJ. The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma. J Biol Chem 2010;285:27487-98.
56. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, et al. Functions of S100 proteins. Curr Mol Med 2012;12:1-34.
57. Xia Z, DePierre JW, Nassberger L. The tricyclic antidepressants clomipramine and citalopram induce apoptosis in cultured human lymphocytes. J Pharm Pharmacol 1996;48:115-6.